Vimarsana
Biggest News Aggregation in the World

Ignyta Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ignyta Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ignyta Inc Today - Breaking & Trending Today

Global Auto-Immune Diseases Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape - Vimarsana News

Global Auto-Immune Diseases Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

/PRNewswire/ -- The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board - Vimarsana News

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board

Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused

TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board - Vimarsana News

TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors - Vimarsana News

Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors

Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, announced today the appointment of Dr. Adrian Senderowicz to its Board of Directors. Dr. Senderowicz is a board-certified

Neuroblastoma - Vimarsana News

Neuroblastoma

Shares of Ignyta Inc (NASDAQ: RXDX) were trading higher by more than 6 percent during Monday's pre-market session after the company announced that the FDA designated its entrectinib, a lead product candidate an Orphan Drug for the treatment of neuroblastoma. The FDA grants Orphan Drug... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to: